| Affiliation: | 1. Viecuri Medical Center, Venlo, The Netherlands, and Radboud University Medical Center, Nijmegen, The Netherlands;2. Dr. Jansen has received consulting fees, speaking fees, and/or honoraria from AbbVie, Bristol‐Myers Squibb, Roche, Janssen, Novartis, and Menarini (less than $10,000 each).;3. University of Auckland, Auckland, New Zealand;4. Dr. Dalbeth has received consulting fees, speaking fees, and/or honoraria from Takeda, Teijin, Menarini, Pfizer, and Fonterra (less than $10,000 each) and AstraZeneca/Ardea (more than $10,000);5. she holds a patent for Fonterra milk products for gout.;6. Radboud University Medical Center, Nijmegen, The Netherlands;7. University of Pennsylvania, Philadelphia;8. Dr. Schumacher has received consulting fees from Novartis, Regeneron, AstraZeneca, and Metabolex (less than $10,000 each).;9. University of Otago, Wellington, New Zealand;10. Boston University School of Medicine, Boston, Massachusetts;11. Dr. Choi has received consulting fees, speaking fees, and/or honoraria from AstraZeneca (less than $10,000) and Takeda (more than $10,000).;12. University of Florida, Gainesville;13. Dr. Edwards has received consulting fees, speaking fees, and/or honoraria from AstraZeneca, Crealta, CymaBay, and Takeda (less than $10,000 each).;14. Frédéric Lioté, MD, PhD: INSERM UMR 1132, Hôpital Lariboisière, AP‐HP, and Université Paris Diderot, Sorbonne Paris Cité, Paris, France;15. Dr. Lioté has received consulting fees, speaking fees, and/or honoraria from Novartis, Ardea, AstraZeneca, Ipsen, Menarini, and Savient (less than $10,000 each) and unrestricted academic grants from Novartis, AstraZeneca, Ipsen, Menarini, Savient, and Mayoly‐Spindler.;16. McMaster University Medical Centre, Hamilton, Ontario, Canada;17. University of Edinburgh, Edinburgh, UK;18. Hospital Universitario Cruces and BioCruces Health Research Institute, Vizcaya, Spain;19. Dr. Perez‐Ruiz has received consulting fees, speaking fees, and/or honoraria from AstraZeneca, Menarini, Pfizer, and CymaBay (less than $10,000 each). Dr. Saag has received consulting fees, speaking fees, and/or honoraria from Amgen, AstraZeneca/Ardea, Crealta, and Takeda (less than $10,000 each).;20. University of Alabama at Birmingham;21. Birmingham VA Medical Center and University of Alabama at Birmingham, and Mayo Clinic College of Medicine, Rochester, Minnesota;22. Dr. Singh has received consulting fees, speaking fees, and/or honoraria from Regeneron, Allergan, and Savient (less than $10,000 each) and Takeda (more than $10,000) and research grants from Savient and Takeda.;23. Gilead Sciences, Foster City, California);24. Dr. Sundy has received consulting fees from Merck, Lilly, AstraZeneca, Metabolex, Novartis, and Navigant (less than $10,000 each).;25. University Hospital Carl Gustav Carus, Dresden, Germany;26. Dr. Tausche has received consulting fees, speaking fees, and/or honoraria from Berlin‐Chemie Menarini (less than $10,000) and has served as an expert witness on behalf of Ardea Biosciences/AstraZeneca and Novartis.;27. Hospital General de Mexico, Mexico City, Mexico;28. University of Michigan Health System, Chelsea;29. Dr. Taylor has received consulting fees, speaking fees, and/or honoraria from Pfizer, AstraZeneca, AbbVie, and Roche (less than $10,000 each). |
